1. Introduction {#s0005}
===============

Melanoma incidence continues to increase and accounts for over 79% of skin cancer-related deaths ([@bb0295]; [@bb0305]). The 5-year survival rate is very high among early stages; \>96% for *in situ* melanomas and 92% at stage I ([@bb0030]; [@bb0025]). However, survival decreases markedly to 67% at stage II, and 49% at stage III ([@bb0030]; [@bb0025]). Thus the importance of early diagnosis of melanoma is paramount. Full-body visual skin examination is the primary tool for secondary prevention of skin cancer, particularly melanoma. Regular whole-body skin examinations are associated with reduced melanoma thickness at diagnosis and improved survival rate ([@bb0020]), which has been found for both provider ([@bb0035]) and self-administered skin exams ([@bb0005]).

Though many providers use whole body skin exams as a standard method of skin cancer detection ([@bb0300]), surprisingly little research has examined additional benefits, or potential harms of screening ([@bb0040]; [@bb0320]). This relative gap in the literature contributed to consecutive "insufficient" ("I") ratings by the US Preventative Services Task Force (USPSTF) ([@bb0040]). In 2016, the USPSTF issued another "insufficient" statement regarding the utility of visual skin examinations for skin cancer screening of asymptomatic healthy adults ([@bb0040]) in primary care settings. Some of the concerns mentioned by USPSTF included the over-diagnosis and an increase in unnecessary skin biopsies, which we addressed in previous work ([@bb0325]). They also cited an inability to adequately compare the benefits and harms of skin examinations, including potential harm on psychosocial wellbeing ([@bb0040]).

Potential psychosocial effects of cancer screening, such as anxiety and distress have contributed to revised screening recommendations for some cancer types, including breast and colon cancer ([@bb0090]; [@bb0080]). Screenings for several types of cancer have been found to be associated with largely beneficial or non-harmful results ([@bb0220]; [@bb0275]; [@bb0200]; [@bb0310]). However, the effects on these outcomes have not been reported for skin cancer screening.

The purpose of this paper is to document the results of a survey assessment of the positive and negative psychosocial consequences, as well as post-screening skin cancer prevention attitudes and behaviors of patients who were screened by primary care providers at the University of Pittsburgh Medical Center (UPMC) initiative to screen for melanoma. Prior assessments of this initiative have shown that skin surgery and dermatology visits are not increased among patients seen by participating providers ([@bb0325]) and detected melanomas were more numerous and thinner among screened patients ([@bb0120]).

As has been described elsewhere ([@bb0325]), the screening was conducted by primary care providers (PCPs; ie, physicians and other clinicians) during routine visits. These clinicians were offered online training using a modified version of the INFORMED (INternet course FOR Melanoma Early Detection) program ([@bb0110]). INFORMED (available at [www.visualdx.com/educational-resources](http://www.visualdx.com/educational-resources){#ir0005}) has been previously shown to improve PCP skills related to melanoma detection, including the ability to appropriately reassure patients who have benign lesions that may resemble melanoma, such as seborrheic keratoses ([@bb0215]; [@bb0250]). It was anticipated that the ability to appropriately reassure patients would reduce the risk of screening-induced harms.

2. Methods {#s0010}
==========

In the UPMC melanoma screening program (described elsewhere ([@bb0325])), UPMC PCPs completed a modified version of the INFORMED training beginning in January 2014 to improve the early detection of melanoma and keratinocyte carcinomas (basal and squamous cell carcinomas of the skin) ([@bb0115]; [@bb0255]). The electronic medical record (EMR) included a health maintenance function (a new check box) to indicate screening for melanoma. For this study, UPMC staff drew a sample of all patients ≥35 years of age who were indicated in the EMR having a visit where a screen was done in the 2 PCP practices.

Letters were sent to patients offering an opportunity to opt out of the survey. Consent for the survey was conducted by telephone at the time of the survey. The protocol for obtaining verbal consent from all participants was approved by the appropriate IRB committees. Baseline surveys, representing the first contact with patients, were conducted in 2015 in batches to minimize a response bias of only completing surveys of easy-to-reach patients. Initial surveys were conducted an average of 5 months after the index PCP appointment, with a second survey following three months after the baseline contact or after a subsequent dermatology appointment.

Despite the consistent EMR presence of a checked box to indicate screening, not all patients reported in their baseline survey that they had had their skin thoroughly examined for early detection of cancer. Screening was then defined based on patient responses to several questions including: whether screening was performed, the level of undress during examination and whether certain body parts were examined. One hundred and twenty-two patients (65%) reported having their skin examined; 60 patients reported that their entire skin was examined specifically for skin cancer, and 76 patients reported being screened, and reported being completely undressed with or without undergarments and had at least two out of three body parts examined (the back, abdomen, and calves). For the purposes of these analyses, "thoroughly screened," patients were those 76 (41%), and, "not thoroughly screened patients," were those 111 patients (59%) who did not indicate that they had their whole body screened for skin cancer, did not disrobe or have two of the three body parts examined.

2.1. Measures {#s0015}
-------------

*Demographics*: Characteristics queried in the baseline survey included: gender; household composition (lived with both adults and children, just children, just adults, you live alone); education (8th grade or less, some high school, high school graduate or General Education Degree (GED), technical school or junior college graduate, some college, college graduate, post graduate or professional degree, other); ethnicity (Hispanic, yes or no); Race (American Indian/Alaska Native, Asian, Native Hawaiian or Pacific Islander, Black or African American, White/Caucasian or other); Household income (\<\$20,000, \$20,000--\$40,000, \$40,001--\$80,000, \>\$80,000).

*The Hospital Anxiety and Depression rating scale (HADS)* is a 14-item questionnaire, with 7 questions measuring anxiety (HADS-A) and 7 questions measuring depression (HADS-D) on a self-reporting scale running from 0 to 3 ([@bb0265]; [@bb0215]; [@bb0250]). Total scores ranged from 0 to 21, with higher scores indicating more severe anxiety or depression. Based on previous data, a cut-off score of 8 or more is considered to be optimal for allocating patients into groups with high and low depressive and anxiety symptoms ([@bb0050]).

*The Spielberger State-Trait Anxiety Index -- form 6 (STAI-6)*, is a validated 6-item version of the State Trait Anxiety Inventory, a self-administered measure to assess general anxiety. Scores range from 20 to 80 with higher scores indicating more severe anxiety. An individual is considered highly anxious with a score of over 44 ([@bb0210]; [@bb0185]).

*Psychological Consequences Questionnaire (PCQ)* is a self-administered questionnaire designed to measure positive and negative psychological impact of a mammogram ([@bb0100]; [@bb0235]). The PCQ measures the consequence of screening on three major life domains: emotional, defined as the psychological aspects of a person\'s behavior; physical, defined as the impact on a person\'s physical functioning, including activities of daily living; and social functioning, defined as the effect on a person\'s social functioning and how she relates to others. Scoring of the negative consequences within each dimension vary from 0 to 3 with higher score indicating more distress associated with screening (PCQ -- negative). Cumulative scores could range in the emotional dimension from 0 to 15, physical from 0 to 12, and social from 0 to 9.

The positive emotional, physical, and social functioning consequences of the screening experience ([@bb0100]) are also queried with scores in each dimension varying from 0 to 3 with higher score indicating less distress and more positive consequence associated with screening. Cumulative scores could range in the emotional dimension from 0 to 15, physical from 0 to 9, and social from 0 to 6.

*The 12-Item Short Form Health Survey (SF-12)* is a self-administered questionnaire developed to measure health-related quality of life across age, disease, and treatment group ([@bb0125]). The SF-12 consists of 12 items in the physical and mental domains referring to thoughts and feelings in the past. The original form refers to one week as the reference time period; this study modified to ask about thoughts and feelings in the past four weeks. The Physical Component Summary (PCS) is an index of overall physical functioning and the Mental Component Summary (MCS) is an index of emotional and mental health. Standardized scores range from 0 to 100, with higher scores indicating better self-perceived health.

Other questions included the experience of their skin exam (embarrassment, skin biopsies done), degree of education provided at their visit (ability to identify a concerning lesion, written materials), potential concerns regarding skin cancer (seriousness of diagnosis and financial burden), and skin cancer prevention practices (UV protection, monthly and annual self-skin exams, quality of self-skin exam, desire for future skin exams).

2.2. Statistical analysis {#s0020}
-------------------------

Patients were not obligated to answer all questions so some missing values are represented. Differences between the thoroughly screened and not thoroughly screened cohorts were evaluated using Fisher\'s exact test. For continuous variables, normality was assessed using the Shapiro-Wilk test. The SF-12 PCS follow-up screen met assumptions of normality (*p* \> 0.05 for Shapiro-Wilk test of normality for both groups). Assumptions of normality were not met for scores on the HADS, STAI-6, PCQ, and SF-12 MCS screens (*p* \< 0.001 for Shapiro-Wilk test of normality for both groups). Accordingly, non-parametric statistics were used for analysis. Welch\'s two sample *t*-test was used to test for differences between the thoroughly screened and not thoroughly screened groups for normally distributed variables and Wilcoxon rank sum test was used to test for differences between groups for variables that were non-normally distributed. The alpha criterion was set at \<0.05. Statistical analysis was performed during 2017 using R 3.2.3 ([@bb9000]).

3. Results {#s0025}
==========

3.1. Sample population {#s0030}
----------------------

The 187 participants surveyed at baseline represented 24% of the patient lists; 126 (67%) of those reached at baseline completed the follow up survey ([Fig. 1](#f0005){ref-type="fig"}). At baseline, 27% of patients called declined to complete the survey, whereas 49% were not able to be reached or complete the survey; at follow-up 1% refused the survey, and 32% were not able to be reached.Fig. 1Consort diagram for patients contacted for baseline and follow-up surveys.Fig. 1

Demographic characteristics are presented in [Table 1](#t0005){ref-type="table"}. The patient population included 57% men, which differed between the thoroughly screened (70%) and not thoroughly screened (49%) groups (*p* \< 0.01). The sample was also predominantly Caucasian (90%) and college educated (71%) with an annual household income of \>\$80,000 (56%); 32% had incomes \$40,000--\$80,000. While the majority of patients (79%) did not have a personal history of skin cancer 59% reported having a family history of melanoma, and 26% reported knowing someone who died from melanoma. There were no significant differences in history of skin examination or personal or family history of melanoma between those who were thoroughly screened and not thoroughly screened.Table 1Characteristics of participants grouped by screening status.Table 1All % (n)Thoroughly screened % (n)Not thoroughly screened % (n)*p*-Value (2 sided)Sex \*Female42.8 (80)30.3 (23)51.4 (57)0.0042Male57.2 (107)69.7 (53)48.6 (54)RaceBlack or African American5.3 (10)4.1 (5)7.7 (5)0.4378White89.8 (168)90.2 (110)89.2 (58)Other4.8 (9)5.7 (7)3.1 (2)EducationSome high school, High school grad or GED9.7 (18)10.7 (13)7.7 (5)0.5275Technical school or junior college grad, some college18.8 (35)19.8 (24)16.9 (11)College graduate59.1 (110)55.4 (67)66.2 (43)Post grad or professional degree12.4 (23)14 (17)9.2 (6)Annual household income\<\$20,0004.8 (8)2.9 (2)6.1 (6)0.4390\$20,001--40,0007.2 (12)7.4 (5)7.1 (7)\$40,001--80,00031.9 (53)38.2 (26)27.6 (27)\>\$80,00056 (93)51.5 (35)59.2 (58)Personal history of skin cancerYes20.9 (39)21.1 (16)20.7 (23)0.9562No79.1 (148)78.9 (60)79.3 (88)Family history of melanomaYes58.6 (109)61.8 (47)56.4 (62)0.4559No41.4 (77)38.2 (29)43.6 (48)Knows someone who died from melanomaYes25.7 (48)30.3 (23)22.5 (25)0.2339No74.3 (139)69.7 (53)77.5 (86)Personal history of skin examYes40.1 (75)39.5 (30)40.5 (45)0.8838No59.9 (112)60.5 (46)59.5 (66)[^1]

Psychosocial outcome measures by screening status are summarized in [Table 2](#t0010){ref-type="table"}. On the baseline survey participants reporting that they were thoroughly screened scored significantly higher on positive emotional consequences compared with those who were not thoroughly screened (*p* \< 0.001), but this difference did not persist to the follow-up measure approximately three months later. There were no significant differences between thoroughly screened and not thoroughly screened patients at baseline or follow-up for the HADS anxiety and depression, STAI-6, negative PCQ, and SF-12 PCS. Though similar at baseline, at follow-up thoroughly screened patients scored slightly, but significantly lower on the SF-12 compared with not thoroughly screened patients (*p* = 0.026).Table 2Psychosocial measures in participants thoroughly screened and not thoroughly screened at baseline and follow-up.Table 2ScalesBaselineFollow-upThoroughly screened\
n = 76Not thoroughly screened\
n = 1112 sided *p*-valueThoroughly screened\
n = 53Not thoroughly screened\
n = 732 sided *p*-valueMedian (range)Median (range) (n)Median (range) (n)Median (range) (n)HADS-A3.5 (0--15)4.0 (0--18)0.93 (0--14)4 (0--16)0.6HADS-D1 (0−20)2 (0--15)0.11 (0--19)2 (0−12)0.3STAI-623.3 (20--70)26.7 (20--80)0.623.3 (20--80)23.3 (20--63.7)0.6Negative emotional consequences PCQ0 (0--9)0 (0--8)0.50 (0−10)0 (0−11)0.8Negative physical consequences PCQ0 (0--5)0 (0--4)0.30 (0--8)0 (0--10)0.8Negative social consequences PCQ0 (0--8)0 (0--6)0.70 (0--7)0 (0--9)0.8Positive emotional consequences PCQ6 (0--15)4 (0--15)0.00027 (0--15)6 (0--15)0.6Positive physical consequences PCQ0 (0--9)0 (0--9)0.40 (0--9)0 (0--9)0.9Positive social consequences PCQ0 (0--6)0 (0--6)0.50 (0--6)0 (0--6)0.8SF-12 PCS^a^40.6 (30.9--47.3)^⁎^40.5 (31.4--48.7)0.741.0 (4.0)40.4 (3.8)0.4SF-12 MCS49.3 (36.9--56.6)^⁎^49.1 (28.5--60.5)0.449.2 (28.6--56.9)49.5 (35.5--59.2)0.02[^2]

Skin cancer prevention practices by screening status at baseline and follow-up are summarized in [Fig. 2](#f0010){ref-type="fig"}. At both baseline and follow-up, thoroughly screened participants were more likely to have their skin annually examined by a provider than patients who were not thoroughly screened (*p* = 0.035, and 0.031 respectively). Thoroughly screened patients more likely than patients who were not thoroughly screened to report that they will perform previous skin self-examinations in the next year (*p* = 0.034), though the difference at baseline was not significant. Also, the likelihood of that they will perform skin self-examinations monthly was not different between groups at either baseline or follow-up survey.Fig. 2Participants "very likely" to perform prevention practices by baseline and follow-up screening status.Fig. 2

Skin cancer education by screening status at baseline is summarized in [Table 3](#t0015){ref-type="table"}. Overall thoroughly screened participants received the education they desired by their providers and were more likely than those not thoroughly screened to be recommended by their provider to perform regular total body skin self-exams, and to receive written information about skin cancer screening (all *p* \< 0.0001). No significant differences were found between groups regarding satisfaction and of written materials as well as perception of adequacy of written materials regarding skin cancer. Thoroughly screened individuals reported increased ability to identify a concerning skin lesion after their skin exam compared to those not thoroughly screened (*p* = 0.0041), and were more likely to recommend others to have their skin examined (*p* = 0.011).Table 3Skin cancer education provided in patients thoroughly screened and not thoroughly screened at baseline.Table 3QuestionResponse optionsBaseline*p*-Value (2 sided)Thoroughly screened\
% (n)Not thoroughly screened\
% (n)In your appointment, did you get the information you needed about skin cancer?Yes72.9 (51)28.8 (32)\<0.0001No27.1 (19)71.2 (79)At your visit, did your provider recommend that you perform regular total body skin self-exams?Yes56.9 (41)25.9 (28)\<0.0001No43.1 (31)74.1 (80)After your visit, how likely would you be able to identify a concerning spot on your skin?Very likely40 (30)26.1 (29)0.0026Somewhat likely46.7 (35)38.7 (43)Not likely13.33 (10) (8)35.1 (39)After receiving your skin cancer screening, did you suggest that anyone else get screened?Yes21.1 (16)8.1 (9)0.01No86.6 (162)78.9 (60)Was written information on skin cancer screening provided to you by your provider\'s office?Yes31.3 (21)5.6 (6)\<0.0001No68.7 (46)94.4 (101)How well did you understand the written information that was provided to you about skin cancer screening?Very well76.2 (16)60 (3)0.07Somewhat well or a little bit23.8 (5)40 (3)How satisfied were you with the written materials that you received?Very satisfied71.4 (15)66.7 (4)0.8Somewhat satisfied28.6 (6)33.3 (2)How adequate did you find the written materials that you received?Very adequate61.9 (13)66.7 (4)0.8Somewhat or not very adequate38.1 (8)33.3 (2)

4. Discussion {#s0035}
=============

We examined psychosocial and behavioral consequences of skin cancer screening in primary care and found no evidence of harms in terms of distress and anxiety, but did find indications of benefit in terms of skin cancer prevention intentions or activities. Numerous worldwide studies have examined the benefits of physician-led skin screening on early melanoma detection ([@bb0005]; [@bb0270]; [@bb0280]; [@bb0010]; [@bb0130]; [@bb0015]; [@bb0075]; [@bb0140]). However, there are no known previous studies that investigate the potential psychological benefits or harms from skin cancer screening ([@bb0320]). The USPSTF cited these unknown potential psychological harms in support for its "insufficient" rating ([@bb0040]). Our results suggest that screening was not associated with negative emotions and may positively influence emotional wellbeing. While we note differences between patients thoroughly screened and not, the reported HADS, STAI-6, PCQ, and SF-12 scores for all patients were within normal range, well below any threshold suggestive of anxiety, depression, emotional and social distress, and physical impediment.

The absence of psychological harm and even potential future prevention benefits from visual skin cancer screening is consistent with evidence of psychological impact found for other cancer screens. Mammographic breast cancer screening has been associated with low levels of distress immediately before, during or after the screening ([@bb0090]). The mammogram itself does not inflict any psychosocial harm; and a negative result can even reduce anxiety ([@bb0085]).

Screenings for other cancers are associated with largely beneficial or non-harmful results ([@bb0220]; [@bb0275]; [@bb0200]; [@bb0310]). Few studies have found any psychosocial harm associated with colonoscopies ([@bb0090]; [@bb0220]; [@bb0240]). Improved health-related quality of life ([@bb0275]; [@bb0230]) and reduced anxiety ([@bb0315]; [@bb0290]) have even been found after colonoscopies or fecal occult blood tests. Similar to mammograms, patients who receive a negative colorectal cancer screening result report significant decreases in anxiety and improvement in health-related quality of life ([@bb0150]). For cervical cancer, most investigators have found no negative impact of HPV testing on psychosocial wellbeing ([@bb0200]; [@bb0160]).

The greatest psychological cost of cancer screening is likely to derive from false positive results. In the case of mammography, most of the evidence suggests that an abnormal result, not the mammogram itself, is a significant cause of anxiety, at least in the short term ([@bb0080]; [@bb0310]; [@bb0085]; [@bb0245]). Similarly, for other invasive cancer screenings like for cervical and colorectal cancer, psychosocial harm has mostly been associated with a false positive result which decreases over time and with patient education ([@bb0180]; [@bb0260]; [@bb0155]; [@bb0055]; [@bb0165]; [@bb0225]; [@bb0070]). It has been noted that in the long term these effects lessen, especially after patient education, follow-up examination, and reassurance ([@bb0310]; [@bb0085]; [@bb0170]). Our own research has shown that no detrimental differences were found between survey respondents in this study who were biopsied compared to those who were not ([@bb0195]), though the sample size was not large enough to examine those with false-positive results compared with others.

Our results, particularly regarding intention to practice skin cancer prevention after being screened contrast to some studies that examine the psychological impact of a melanoma diagnosis. The diagnosis of melanoma, even at early stages is known to negatively affect psychosocial wellbeing ([@bb0285]; [@bb0060]; [@bb0065]), and may even affect recovery and disease morbidity ([@bb0095]; [@bb0145]), as well as prevent skin cancer prevention practices like regular skin examinations and UV protection ([@bb0065]; [@bb0105]; [@bb0135]), though other research has found positive skin self-examination practices after diagnosis ([@bb0205]; [@bb0045]). We found that intention to practice skin cancer prevention in the future was significantly greater for participants who were thoroughly screened compared to those who were not ([Fig. 2](#f0010){ref-type="fig"}), though this practice was not the primary objective of the screening practices. These results suggest that beyond providing potential benefits in psychosocial wellbeing, practitioner provided skin cancer screening may promote better skin cancer prevention practices outside of the clinic.

The quality of skin cancer education varied greatly between participants who were thoroughly screened and not thoroughly screened at their primary care visit. The greater post-screening prevention behaviors between groups may stem from provider counseling, the screening itself, or both. Compared with patients who were not thoroughly screened, patients who were thoroughly screened reported that they received the information they wanted about skin cancer, written information on skin cancer, and recommendations to perform regular skin self-exams that resulted in higher confidence to identify a concerning lesion on their body and to recommend skin cancer screening to others. Patients who receive practitioner-provided skin cancer screening may be more capable of performing skin self-exams, and may be better equipped at identifying high-risk lesions.

5. Limitations {#s0040}
==============

The present study has several limitations that must be considered along with these results. This study only evaluates patients of two practices within the UPMC setting. We do not have demographic information and other characteristics of the providers and patients of those practices to determine the potential generalizability to the entire UPMC system. Additionally, providers selected which patients were screened and documented their screening status in their chart based on their own clinical judgement, which may have been biased. However, we are not able to compare the patients who were and were not screened by providers to evaluate those potential biases. Also, within the set of patients screened, our survey was completed with a relatively small proportion of all patients screened in that time period. Without demographic or other information on patients who did not complete the survey, we are not able to describe the potential selection biases introduced by participation. Also, the time between the patient\'s visit and each of the surveys varied, making it difficult to clearly assess effects of time on performance of outcome measures. However, all scores for psychosocial wellbeing were well below threshold, and a difference of a few weeks would likely have had minimal impact on the outcome. Our survey study was also non-representative of at-risk Caucasian patients as a very high proportion were highly educated and of higher income. More than half of the respondents were male, which is curious given the contrast with the higher proportion of female respondents in our previous work with primary care providers ([@bb0330]; [@bb0190]). Highly educated women, compared to women with low education levels, are less likely to report anxiety related to breast cancer ([@bb0175]), but it is not clear if the same relationship exists between education and anxiety related to skin examination. Our statistical power to detect differences between patients thoroughly screened and others was limited. Finally, none of the psychosocial measures were designed specifically for skin cancer screening, although there are no validated measures for psychosocial wellbeing after skin cancer screening. Furthermore, these scales have been more successful at highlighting psychosocial wellbeing after a false-positive result from a screening exam, which is an important outcome of skin screening by primary care providers, but was not within the scope of this study. A much larger study would be required to assess anxiety and other psychosocial measures in association with biopsy, and more narrowly with false positive results.

6. Conclusions {#s0045}
==============

In the current climate of healthcare reform and cost-cutting, recommendations from the USPSTF and other organizations are crucial to ensure that patients receive appropriate screening. Without recommendations for screening, primary care providers are less likely to provide skin cancer screening, potentially resulting in missed skin cancer diagnoses, with missed opportunities to encourage skin cancer prevention practices. Our results suggest that provider screening results in important benefits to future skin cancer self and provider screening.
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[^1]: *Note*: \* indicates statistical significance (*p* \< 0.01).

[^2]: n = 74 for SF-12 PCS and SF-12 MCS initial screening data of those thoroughly screened.
